Published in Int J Cancer on July 01, 2008
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
HIV infection and the risk of cancers with and without a known infectious cause. AIDS (2009) 3.13
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A (2014) 2.95
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med (2010) 2.33
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution. Blood (2012) 2.20
Moving forward in HIV-associated cancer. J Clin Oncol (2014) 2.14
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS (2010) 2.04
HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev (2011) 2.02
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS (2014) 1.86
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol (2009) 1.84
Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis (2010) 1.78
Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol (2010) 1.77
Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS (2009) 1.73
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett (2011) 1.71
Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities. AIDS (2009) 1.64
Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: a retrospective study on the impact of HIV infection and its treatment. J Acquir Immune Defic Syndr (2011) 1.63
The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis (2012) 1.62
Epidemiology of lung cancer. Semin Intervent Radiol (2013) 1.61
HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era. J Clin Oncol (2012) 1.55
Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer (2010) 1.54
Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS (2011) 1.52
Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya. J Low Genit Tract Dis (2012) 1.50
Lung cancer incidence and survival among HIV-infected and uninfected women and men. AIDS (2015) 1.47
Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One (2013) 1.46
Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer (2009) 1.42
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS (2014) 1.41
The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med (2011) 1.40
Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37
Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. J Clin Oncol (2010) 1.37
The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One (2010) 1.34
Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr (2010) 1.33
The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer (2010) 1.32
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. Clin Infect Dis (2013) 1.31
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr (2014) 1.30
Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress. PLoS Pathog (2010) 1.30
Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults. Clin Infect Dis (2014) 1.28
Reduced risk of prostate cancer in U.S. Men with AIDS. Cancer Epidemiol Biomarkers Prev (2010) 1.23
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS (2009) 1.22
Cancer screening in patients infected with HIV. Curr HIV/AIDS Rep (2011) 1.21
Mortality due to cancer among people with AIDS: a novel approach using registry-linkage data and population attributable risk methods. AIDS (2012) 1.19
Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS (2013) 1.19
Excess cancers among HIV-infected people in the United States. J Natl Cancer Inst (2015) 1.19
Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men. Curr Infect Dis Rep (2010) 1.17
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era. Int J Cancer (2014) 1.16
Growing older with HIV/AIDS: new public health challenges. Am J Public Health (2013) 1.15
HIV infection in the etiology of lung cancer: confounding, causality, and consequences. Proc Am Thorac Soc (2011) 1.13
Colorectal lymphoma. Clin Colon Rectal Surg (2011) 1.13
The impact of HAART on HPV-related cervical disease. Curr HIV Res (2010) 1.12
HIV-Associated Venous Thromboembolism. Mediterr J Hematol Infect Dis (2011) 1.11
Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis. J Biol Chem (2010) 1.10
HIV infection, aging, and immune function: implications for cancer risk and prevention. Curr Opin Oncol (2012) 1.10
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol (2012) 1.09
Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS (2012) 1.07
A cross-sectional description of social capital in an international sample of persons living with HIV/AIDS (PLWH). BMC Public Health (2012) 1.07
HIV and cancer in Germany. Dtsch Arztebl Int (2011) 1.05
Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS (2014) 1.05
Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antivir Ther (2009) 1.04
The spectrum of cancers in West Africa: associations with human immunodeficiency virus. PLoS One (2012) 1.04
Age at cancer diagnosis for blacks compared with whites in the United States. J Natl Cancer Inst (2015) 1.03
Importance of microbial natural products and the need to revitalize their discovery. J Ind Microbiol Biotechnol (2013) 1.03
Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology (2010) 1.02
HIV pathogenesis: the host. Cold Spring Harb Perspect Med (2012) 1.02
HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy. Blood (2011) 1.02
Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol (2013) 1.01
Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood (2011) 1.00
High cancer-related mortality in an urban, predominantly African-American, HIV-infected population. AIDS (2013) 0.99
HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infect Agent Cancer (2011) 0.99
Evolving spectrum and incidence of non-AIDS-defining malignancies. Curr Opin HIV AIDS (2009) 0.99
Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study. J Int AIDS Soc (2011) 0.99
Structural evaluation of new human polyomaviruses provides clues to pathobiology. Trends Microbiol (2010) 0.98
Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus. Am J Cancer Res (2011) 0.98
Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer (2011) 0.98
Age, stress, and isolation in older adults living with HIV. AIDS Care (2013) 0.97
Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc (2013) 0.97
Cervical cancer and the global health agenda: Insights from multiple policy-analysis frameworks. Glob Public Health (2013) 0.96
Cutaneous malignancies among HIV-infected persons. Arch Intern Med (2009) 0.96
Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications. Cell Mol Immunol (2012) 0.96
Challenges in treating malignancies in HIV in Nigeria. Curr Opin Oncol (2009) 0.96
Lung cancer in HIV Infection. Clin Lung Cancer (2011) 0.95
Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol Biomarkers Prev (2010) 0.95
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. J Int AIDS Soc (2010) 0.94
Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94
Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers? J Natl Cancer Inst (2009) 0.94
Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Clin Dev Immunol (2012) 0.93
11. Cancers attributable to infection in the UK in 2010. Br J Cancer (2011) 0.93
A Case of Cutaneous Plasmablastic Lymphoma in HIV/AIDS with Disseminated Cryptococcus. Case Rep Oncol Med (2013) 0.93
A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer (2010) 0.93
The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer (2012) 0.93
Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. Oral Oncol (2014) 0.93
Epidemic of lung cancer in patients with HIV infection. Chest (2013) 0.92
Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis. Cancer Prev Res (Phila) (2012) 0.92
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
Estimated HIV incidence in the United States, 2006-2009. PLoS One (2011) 13.03
A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr (2010) 4.32
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
The characterization of twenty sequenced human genomes. PLoS Genet (2010) 3.72
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011. MMWR Morb Mortal Wkly Rep (2014) 3.60
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst (2007) 3.28
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study. Cancer (2008) 3.13
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97
Reported drop in mammography : is this cause for concern? Cancer (2007) 2.91
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood (2006) 2.90
Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med (2008) 2.90
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78
Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst (2013) 2.76
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS (2010) 2.62
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50
Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis (2003) 2.42
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep (2008) 2.32
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med (2012) 2.18
Uncertainties associated with incidence estimates of HIV/AIDS diagnoses adjusted for reporting delay and risk redistribution. Stat Med (2005) 2.15
Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst (2011) 2.13
KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog (2006) 2.06
Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer (2010) 2.05
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition - United States, 2015. MMWR Morb Mortal Wkly Rep (2015) 2.05
Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance. Gastroenterology (2006) 2.04
Relative efficacy of prevention counseling with rapid and standard HIV testing: a randomized, controlled trial (RESPECT-2). Sex Transm Dis (2005) 2.03
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis (2012) 2.01
Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol (2010) 2.00
Prevalence of Diagnosed and Undiagnosed HIV Infection--United States, 2008-2012. MMWR Morb Mortal Wkly Rep (2015) 1.99
APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol (2004) 1.97
Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr (2003) 1.96
Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999. Cancer (2002) 1.93
C-reactive protein and risk of lung cancer. J Clin Oncol (2010) 1.90
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis (2007) 1.88
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86
Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control (2003) 1.85
Parental cancer and the family: a population-based estimate of the number of US cancer survivors residing with their minor children. Cancer (2010) 1.83
HLA-Cw*04 and hepatitis C virus persistence. J Virol (2002) 1.83
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS (2003) 1.81
Hepatocellular carcinoma and other liver disease among Greenlanders chronically infected with hepatitis B virus: a population-based study. J Natl Cancer Inst (2011) 1.80
Characteristics of HIV infection among Hispanics, United States 2003-2006. J Acquir Immune Defic Syndr (2008) 1.79
Breast and cervical cancer screening rates of subgroups of Asian American women in California. Med Care Res Rev (2007) 1.79
The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol (2010) 1.79
HIV in persons born outside the United States, 2007-2010. JAMA (2012) 1.77
Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One (2010) 1.77
Updated annual HIV transmission rates in the United States, 1977-2006. J Acquir Immune Defic Syndr (2009) 1.76
APOBEC3B deletion and risk of HIV-1 acquisition. J Infect Dis (2009) 1.74
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states. J Am Acad Dermatol (2011) 1.70
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (2004) 1.69
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis (2004) 1.69
Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004. Am J Public Health (2006) 1.66
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66
Hepatitis C virus load and survival among injection drug users in the United States. Hepatology (2005) 1.66
HIV among African-born persons in the United States: a hidden epidemic? J Acquir Immune Defic Syndr (2008) 1.65
Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007. PLoS One (2013) 1.61
Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope (2007) 1.61
Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer (2004) 1.61
Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci U S A (2002) 1.61
Commentary: meta-analysis of individual participants' data in genetic epidemiology. Am J Epidemiol (2002) 1.59
Epidemiology of HIV in the United States. J Acquir Immune Defic Syndr (2010) 1.58
High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med (2006) 1.56
Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS (2013) 1.53
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol (2003) 1.52
Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis (2006) 1.52
Interrelationships of added sugars intake, socioeconomic status, and race/ethnicity in adults in the United States: National Health Interview Survey, 2005. J Am Diet Assoc (2009) 1.51
Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr (2005) 1.51
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene (2005) 1.49
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS (2003) 1.49
Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS One (2009) 1.48
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis (2010) 1.48
Are physicians' recommendations for colorectal cancer screening guideline-consistent? J Gen Intern Med (2010) 1.44